Skip to content
National Cancer Institute
U.S. National Institutes of Health
| www.cancer.gov
In English |
En español
Search
NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
Clinical Trials Search Results
Page Options
E-Mail This Search
Clinical Trial Questions?
Get Help:
1-800-4-CANCER
or
LiveHelp online chat
Quick Links
Help Using the NCI Clinical Trials Search Form
Educational Materials About Clinical Trials
About NCI's Cancer Clinical Trials Registry
Dictionary of Cancer Terms
NCI Drug Dictionary
View Content for:
Patients
Health Professionals
Display:
Title
Description with:
Locations
Eligibility
Full Trial Description
Custom
Results 1-6 of 6 for your search:
Drug:
adenovirus vector
Find trials that include:
Any drugs shown
Trial Status:
Closed
Hide Search Criteria
Show Search Criteria
Help with Results
Select All on Page
Sort by:
Phase of Trial
Title
Type of Trial
Status of Trial
Age Range
Sponsor of Trial
Protocol IDs
Show
10
25
50
100
200
Results per Page
1.
Phase I Study of Immunization with Adenovirus Encoding the gp100 Melanoma Antigen for Refractory Metastatic Melanoma (Summary Last Modified 08/2000)
Phase:
Phase I
Type:
Treatment
Status:
Completed
Age:
16 and over
Sponsor:
NCI
Protocol IDs:
NCI-95-C-0078C
, NCI-T95-0030N, T95-0030
2.
Phase I Study of Immunization with Adenovirus Encoding the MART-1 Melanoma Antigen for Refractory Metastatic Melanoma (Summary Last Modified 12/1999)
Phase:
Phase I
Type:
Treatment
Status:
Completed
Age:
18 and over
Sponsor:
NCI
Protocol IDs:
NCI-95-C-0079D
, NCI-T94-0195N, T94-0195
3.
Phase I Study of the Pro-Drug Flucytosine (5FC) with a Replication Deficient Adenovirus Vector (AdGVCD.10) Containing the E. Coli Cytosine Deaminase Gene to Metastatic Colorectal Carcinoma of the Liver (Summary Last Modified 04/2000)
Phase:
Phase I
Type:
Treatment
Status:
Completed
Age:
18 and over
Sponsor:
Other
Protocol IDs:
NYH-0695-908
, NCI-V97-1130
4.
Phase I Study of CD40-Ligand (CD154) Gene-Transduced Leukemia Cells in Patients with Chronic Lymphocytic Leukemia
Phase:
Phase I
Type:
Treatment
Status:
Closed
Age:
Over 21
Sponsor:
NCI
Protocol IDs:
UCSD-970976
, NCI-G98-1477
5.
Vaccine Trial for Clear Cell Sarcoma, Pediatric Renal Cell Carcinoma, Alveolar Soft Part Sarcoma and Children With Stage IV Melanoma
Phase:
Phase I
Type:
Treatment
Status:
Closed
Age:
All ages
Sponsor:
Other
Protocol IDs:
05-115
, NCT00258687
6.
Vaccination With Autologous Breast Cancer Cells Engineered to Secrete Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF) in Metastatic Breast Cancer Patients
Phase:
Phase I
Type:
Treatment
Status:
Closed
Age:
18 and over
Sponsor:
Other
Protocol IDs:
05-111
, NCT00317603
Select All on Page
Help with Results
NCI Home
|
Images Version
|
Contact Us
|
Policies
|
Accessibility
|
Viewing Files
|
FOIA
|
Site Help
|
Site Map
A Service of the National Cancer Institute